Transdermal delivery rate control using amorphous pharmaceutical compositions
US8784878B2 · kind B2 · utility
0Cited by
48References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 11, 2012 |
| Grant date | Jul 22, 2014 |
| Priority date | — |
| Expiry date | Dec 30, 2032 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P33/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition for transdermal delivery comprising
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.